Iveta S. Nedeva

Zdrave Str
Sofia, 1431, Bulgaria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Distinct Gut Microbiome Profiles Underlying Cardiometabolic Risk Phenotypes in Individuals with Obesity.

Distinct Gut Microbiome Profiles Underlying Cardiometabolic Risk Phenotypes in Individuals with Obesity.

Journal: Nutrients

Published: December 24, 2025

New Players in Metabolic Syndrome.

New Players in Metabolic Syndrome.

Journal: Metabolites

Published: May 04, 2025

Nutritional Management and Physical Activity in the Treatment of Sarcopenic Obesity: A Review of the Literature.

Nutritional Management and Physical Activity in the Treatment of Sarcopenic Obesity: A Review of the Literature.

Journal: Nutrients

Published: July 07, 2024

Circulating Asprosin Concentrations in Patients with Obesity and Carbohydrate Disturbances.

Circulating Asprosin Concentrations in Patients with Obesity and Carbohydrate Disturbances.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: February 11, 2023

IL-18 Serum Levels in Patients with Obesity, Prediabetes and Newly Diagnosed Type 2 Diabetes.

IL-18 Serum Levels in Patients with Obesity, Prediabetes and Newly Diagnosed Type 2 Diabetes.

Journal: Iranian journal of immunology : IJI

Published: June 29, 2022

Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease.

Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease.

Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Published: April 12, 2022

Increased Serum Pentraxin 3 Is Associated with Prediabetes and Type 2 Diabetes in Obese Patients with Nonalcoholic Fatty Liver Disease.

Increased Serum Pentraxin 3 Is Associated with Prediabetes and Type 2 Diabetes in Obese Patients with Nonalcoholic Fatty Liver Disease.

Journal: Metabolic syndrome and related disorders

Published: November 24, 2021

Neopterin in the Evolution from Obesity to Prediabetes and Newly Diagnosed Type 2 Diabetes.

Neopterin in the Evolution from Obesity to Prediabetes and Newly Diagnosed Type 2 Diabetes.

Journal: Metabolic syndrome and related disorders

Published: February 18, 2021

Lumican in Obese Patients with Nonalcoholic Fatty Liver Disease With or Without Prediabetes.

Lumican in Obese Patients with Nonalcoholic Fatty Liver Disease With or Without Prediabetes.

Journal: Metabolic syndrome and related disorders

Published: August 12, 2020

Relationship between circulating netrin-1 levels, obesity, prediabetes and newly diagnosed type 2 diabetes.

Relationship between circulating netrin-1 levels, obesity, prediabetes and newly diagnosed type 2 diabetes.

Journal: Archives of physiology and biochemistry

Published: July 14, 2020

Impact of testosterone treatment on circulating irisin in men with late-onset hypogonadism and metabolic syndrome.

Impact of testosterone treatment on circulating irisin in men with late-onset hypogonadism and metabolic syndrome.

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male

Published: May 28, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026